GlassScriptPhysician profile
John David Schmitz
NPI 1891782819
$2,601.83
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $583 · 2021: $909.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $477.70 | 2019-2021 | |
| Astellas Pharma US INC | $376.16 | 2019-2021 | |
| Abbvie INC. | $219.94 | 2019-2021 | |
| Amarin Pharma, INC. | $184.95 | 2019-2021 | |
| Lilly USA, LLC | $163.61 | 2019-2021 | |
| Glaxosmithkline, LLC. | $150.88 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $102.20 | 2019-2021 | |
| Amgen INC. | $87.46 | 2019 | |
| Pfizer INC. | $74.76 | 2019-2021 | |
| Eisai INC. | $64.60 | 2021 | |
| Ironshore Pharmaceuticals INC. | $46.26 | 2019-2021 | |
| Genentech USA, INC. | $44.70 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.59 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $41.14 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $40.79 | 2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.98 | 2020-2021 | |
| Stryker Corporation | $36.52 | 2019 | |
| Sunovion Pharmaceuticals INC. | $33.35 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.01 | 2019 | |
| Mylan Specialty L.P. | $28.56 | 2020 | |
| Boston Scientific Corporation | $26.52 | 2019 | |
| Merck Sharp & Dohme LLC | $24.96 | 2019 | |
| Allergan, INC. | $24.76 | 2020 | |
| Abbott Laboratories | $22.27 | 2021 | |
| Nestle Healthcare Nutrition INC. | $19.72 | 2021 | |
| Dynavax Technologies Corporation | $18.80 | 2021 | |
| Xeris Pharmaceuticals, INC. | $17.55 | 2021 | |
| Sobi, INC | $16.76 | 2020 | |
| Cranial Technologies, INC | $15.96 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.85 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.46 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.64 | 2019 | |
| Qiagen, LLC | $13.39 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $13.32 | 2019 | |
| Redhill Biopharma INC. | $12.37 | 2020 | |
| Dexcom, INC. | $11.56 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.46 | 2020 | |
| Shire North American Group INC | $11.27 | 2019 | |
| Bioventus LLC | $11.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schmitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.